Research Wire

WashU’s Rohit Pappu and Tanja Mittag at St. Jude received renewed research funding to continue foundational work in studying the basis of Alzheimer’s disease, ALS and frontotemporal dementia.

WashU Medicine researchers have uncovered new insights into the pharmacology of ketamine that help explain both its rapid benefits and its risks.

A new study from the WashU Brown School finds that transparent management helped keep frontline 988 counselors’ morale strong as new performance metrics were introduced.

WashU researcher Scott VanBommel led the team studying the Curiosity rover’s unexpected discovery of pure sulfur, which offers new clues to conditions on Mars roughly 3 billion years ago.

WashU Medicine researchers led by Jacco Boon show that a novel H5N1 vaccine confers robust protection regardless of prior seasonal flu immunity.

A team of WashU researchers has received a more than $3 million grant from the National Institutes of Health (NIH) to study the mechanisms underlying hallucinations and delusions in schizophrenia.

With a grant from the National Science Foundation, WashU computer engineer Shantanu Chakrabartty will design hybrid neuromorphic and quantum computing systems that could unlock huge energy efficiencies in solving artificial intelligence problems.

WashU Medicine researchers led by Michael E. Belloy (left), an assistant professor of neurology and of psychiatry, identified key genetic targets for potential Alzheimer’s disease therapeutics development.

With a CAREER Award from the National Science Foundation, WashU’s Umar Iqbal proposes to redesign the web with infrastructures that will allow AI agents to reliably use it.

Biologist Keith Hengen, in WashU Arts & Sciences, is applying lessons from the brain to next-generation quantum sensors through a U.S. Department of Energy-funded project.